In clinical research, patient experience is paramount. As new methodologies enter the clinical trial sphere, it’s tricky to know which technologies are right for your team and allow for a smoother trial experience for participants. Our new webinar explores misconceptions surrounding technologies like wearables and eConsent with industry experts, helping you make informed decisions to improve your trial success.
Takeaways from MAGI 2017 West regarding changes taking place in the industry at large and an analysis of what’s driving those changes.
“Configurable” and “customizable” are two commonly-used descriptors for interactive response technology systems that support clinical trials. Interpretations of these terms can vary widely. This webinar discusses definitions and system functionality in the context of configurable and customizable and includes systems development life cycle (SDLC) methodologies, the impact on timelines and cost and common applications in interactive response technology system designs.
For the biopharma industries specifically, AI represents an opportunity to avert the R&D productivity crisis with paradigm-shifting applications such as in-silico drug design, prediction of trial risks and big data analytics. However, with every opportunity, there are risks and challenges, and this blog discusses how pharma needs to address the opacity of AI to ensure trust and credibility with all stakeholders.
Wearables and mobile devices are the tools behind a new kind of clinical trial. Read how when they are paired with complementary technology like eCOA, IRT and other eClinical systems it can drive patient-centric studies that also benefit sponsors and investigator sites.
This article provides practical solutions for overcoming the biggest challenges independent clinical research sites face in data collection. Further, it highlights three key metrics that will help sites improve performance and drive success.
When used successfully, the virtual clinical trial model promises to enroll more patients faster, improve patient retention, and reduce costs. For all their perceived advantages, a virtual model doesn’t suit all studies. Read some challenges of virtual trials as well as when they do and do not work.
Inspection readiness has a significant and measurable impact on staff, trial performance, and study execution. Unfortunately, many organizations begin preparing for an inspection only when a drug or device is filed for approval or when they receive notification of an impending inspection - causing undue stress and burden. Get the checklist for 9 steps to achieve ongoing inspection readiness.
Compromised data collection effectively stalled a clinical trial study of an inflammation control drug. With help from a CRO, important lessons were learned about the need for discipline and following protocol as well as the identification of Russia as a highly desirable site for clinical trials.
Sponsors, CROs, and investigative sites around the world can centralize clinical content processes, oversight, quality management, submissions, and compliance for speed and reduced risk.
goBalto Analyze pProvides real-time access to a wealth of data across your study portfolio, replaces the need for manual preparation of routine reports, and eliminate time wasted on non-productive activities, such as status meetings.
Veeva Vault CTMS is the only modern cloud application that makes it easy for life sciences companies to unify clinical information and processes, streamline trial management, and gain complete visibility across the trial portfolio.
mSource is Medrio's mobile eSource application that includes mPRO, mCapture, and mConsent. All products are native applications and are designed for use in early phase and Phase I research.
CRO manages multiple, complex statistical analysis deliverables for a program of studies, CDISC compliant outputs, and data pooling for NDA submission to the FDA with minimal sponsor oversight.
